NEW RESEARCH OPPORTUNITIES
DISC MEDICINE - BITOPERTIN
Phase 2 Clinical Trial for patients with EPP.
CLICK HERE to receive more information.
A research study is underway to assess treatment with Cimetidine in patients ages 15+ with EPP/XLP. Email email@example.com.
AHP PATIENT EXPERIENCE RESEARCH: 15-minute online survey
AIP PREDISPOSING OR PROTECTIVE GENES: In-depth interview with a genetic specialist. Email firstname.lastname@example.org.
AIP INTERVIEWS: 60-Minute interview with porphyria specialists to discuss patient experience. Email email@example.com.
PORPHYRIA TOGETHER ON FACEBOOK
We welcome you to join Porphyria Together, a new closed Facebook group where you will find helpful information in a safe community setting. JOIN US online!
UPA ON YOUTUBE – SCIENTIFIC ADVISORY BOARD VIDEO SERIES
The UPA Scientific Advisory Board contributed to a video series highlighting responses to questions regarding porphyria diagnosis, management, and treatment. Access videos HERE.
WHAT’S UP WORKSHOP
November 9 @ 7PM ET | 4PM PT
Virtual session will focus on Porphyria Life Hacks + Lessons Learned. Come share your experiences and learn from others. Register HERE.
Pediatric Dermatology Research Alliance (PEDRA)
November 4-5, 2022
UPA exhibiting, Bethesda, MD
AASLD – The Liver Meeting
November 4-5, 2022
UPA exhibiting, Washington, DC.
ASH – Hematology Annual Meeting
December 10-13, 2022
UPA exhibiting, New Orleans, LA
The United Porphyrias Association is committed to improving the quality of life of the porphyria patient community and is relentlessly focused on advancing disease awareness, research, and therapies in all the porphyrias.
A world where patients are free from the pain and challenges of porphyria.
"I was diagnosed at the age of 6 with EPP after my parents noticed that every time I was outside I was experiencing anguishing discomfort. I never fully comprehended my diagnosis until I was able to connect with others. With the help of the UPA, I want to be able to help others live more comfortably with EPP and support the vision of a world where patients are free from the pain and challenges of porphyria. "